AGM/EGMJun 15, 2026, 04:12 PM
Jasper Therapeutics to Hold 2026 Annual Meeting on July 31
AI Summary
Jasper Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on Friday, July 31, 2026, at 10:00 a.m. Pacific Time. Stockholders will vote on the election of two Class II directors, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026, and an advisory vote on named executive officer compensation. The record date for voting is June 5, 2026, with 28,009,802 shares outstanding.
Key Highlights
- Annual Meeting of Stockholders scheduled for July 31, 2026, at 10:00 a.m. PT.
- Meeting will be held virtually via live audio webcast.
- Stockholders to elect two Class II directors: Judith Shizuru, M.D., Ph.D. and Tom Wiggans.
- PricewaterhouseCoopers LLP's appointment as independent auditor for 2026 to be ratified.
- Advisory vote on named executive officers' compensation.
- Record date for voting is June 5, 2026.
- 28,009,802 shares of common stock outstanding as of the record date.
Price Impact
More from JSPR